Literature DB >> 1539291

Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients.

J Wahlberg1, E Hanås, C Bergström, B Fellström, I Skarp-Orberg, L Frödin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1539291

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation.

Authors:  J E Frampton; D Faulds
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

Review 2.  Calcium antagonists. Drug interactions of clinical significance.

Authors:  T Rosenthal; D Ezra
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

3.  Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.

Authors:  Osama A Gheith; Mohamed A Bakr; Mohamed A Fouda; Ahmed A Shokeir; Mohamed Sobh; Mohamed Ghoneim
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

Review 4.  Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients.

Authors:  I R Shilliday; M Sherif
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 5.  Antihypertensive treatment for kidney transplant recipients.

Authors:  Nicholas B Cross; Angela C Webster; Philip Masson; Philip J O'Connell; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.